Pyripyropene A biosynthetic gene

Details for Australian Patent Application No. 2009274832 (hide)

Owner Meiji Seika Kaisha, Ltd.

Inventors Anzai, Hiroyuki; Yamamoto, Kentaro; Tsuchida, Mariko; Oyama, Kazuhiko; Mitomi, Masaaki

Agent Davies Collison Cave

Pub. Number AU-A-2009274832

PCT Pub. Number WO2010/010955

Priority 2009-020591 30.01.09 JP; 2008-270294 20.10.08 JP; 2008-190862 24.07.08 JP

Filing date 24 July 2009

Wipo publication date 28 January 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12P 17/18 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/010955 Priority application(s): WO2010/010955

19 January 2012 Alteration of Name

  The name of the applicant has been altered to Meiji Seika Pharma Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009274876-Therapeutic agent for migraine

2009274738-A polypeptide complex comprising nonpeptidyl polymer having three functional ends